INVA
Price:
$22.49
Market Cap:
$1.66B
Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates w...[Read more]
Industry
Biotechnology
IPO Date
2004-10-05
Stock Exchange
NASDAQ
Ticker
INVA
According to Innoviva, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.13. This represents a change of 60.90% compared to the average of 13.14 of the last 4 quarters.
The mean historical Current Ratio of Innoviva, Inc. over the last ten years is 27.01. The current 21.13 Current Ratio has changed 7.72% with respect to the historical average. Over the past ten years (40 quarters), INVA's Current Ratio was at its highest in in the March 2020 quarter at 166.87. The Current Ratio was at its lowest in in the September 2024 quarter at 1.79.
Average
27.01
Median
12.26
Minimum
2.35
Maximum
80.29
Discovering the peaks and valleys of Innoviva, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 523.50%
Maximum Annual Current Ratio = 80.29
Minimum Annual Increase = -93.92%
Minimum Annual Current Ratio = 2.35
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 14.64 | 523.50% |
| 2024 | 2.35 | -73.99% |
| 2023 | 9.03 | 174.69% |
| 2022 | 3.29 | -93.92% |
| 2021 | 54.02 | -3.51% |
| 2020 | 55.98 | -30.27% |
| 2019 | 80.29 | 129.92% |
| 2018 | 34.92 | 507.76% |
| 2017 | 5.75 | -41.83% |
| 2016 | 9.88 | -37.82% |
The current Current Ratio of Innoviva, Inc. (INVA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
8.67
5-year avg
16.66
10-year avg
27.01
Innoviva, Inc.’s Current Ratio is greater than MiMedx Group, Inc. (5.39), greater than Nektar Therapeutics (10.21), greater than Atai Beckley Inc. (10.02), greater than Syndax Pharmaceuticals, Inc. (5.47), greater than Inhibrx Biosciences, Inc. (6.46), greater than Immatics N.V. (8.78), greater than CureVac N.V. (3.70), less than Enliven Therapeutics, Inc. (40.32), less than Relay Therapeutics, Inc. (22.13), less than Dianthus Therapeutics, Inc. (29.25),
| Company | Current Ratio | Market cap |
|---|---|---|
| 5.39 | $546.63M | |
| 10.21 | $1.19B | |
| 10.02 | $1.49B | |
| 5.47 | $1.68B | |
| 6.46 | $1.37B | |
| 8.78 | $1.31B | |
| 3.70 | $1.05B | |
| 40.32 | $3.15B | |
| 22.13 | $2.78B | |
| 29.25 | $3.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innoviva, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Innoviva, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Innoviva, Inc.'s Current Ratio?
How is the Current Ratio calculated for Innoviva, Inc. (INVA)?
What is the highest Current Ratio for Innoviva, Inc. (INVA)?
What is the 3-year average Current Ratio for Innoviva, Inc. (INVA)?
What is the 5-year average Current Ratio for Innoviva, Inc. (INVA)?
How does the current Current Ratio for Innoviva, Inc. (INVA) compare to its historical average?